ORGANIZATION OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($) |
1 Months Ended | 3 Months Ended | 6 Months Ended | 12 Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
May 21, 2020 |
Mar. 23, 2020 |
Jun. 30, 2022 |
Dec. 31, 2021 |
Jun. 30, 2021 |
Jun. 30, 2022 |
Jun. 30, 2021 |
Dec. 31, 2021 |
Dec. 31, 2020 |
May 18, 2022 |
Mar. 31, 2022 |
Mar. 03, 2022 |
|
| Research And Development Costs | $ 485,184 | $ 566,655 | $ 314,532 | $ 532,644 | $ 485,995 | $ 1,198,780 | $ 633,050 | |||||
| Ownership interest, percentage | 1.38% | 1.38% | 1.38% | 1.38% | 1.38% | |||||||
| Impairment Loss | $ 25,320,555 | $ 25,320,555 | ||||||||||
| Deferred Tax Asset | 4,129,000 | 2,830,000 | ||||||||||
| Advertising And Marketing Costs | $ 30,185 | 35,654 | $ 45,519 | 59,500 | $ 104,738 | $ 96,637 | ||||||
| Valuation Allowance, Percentage | 100.00% | 100.00% | 100.00% | |||||||||
| Common Stock, Shares Authorized | 100,000,000 | 100,000,000 | 100,000,000 | 100,000,000 | 100,000,000 | 7,917 | ||||||
| Common Stock, Par Value | $ 0.00001 | $ 0.00001 | $ 0.00001 | $ 0.00001 | $ 0.00001 | $ 0.00001 | $ 0.01 | |||||
| Loss From Operation | $ (1,671,368) | $ (1,314,688) | $ (4,430,386) | $ (2,281,702) | $ (5,555,234) | $ (28,269,589) | ||||||
| Property, Plant and Equipment [Member] | ||||||||||||
| Loss From Operation | $ (39,434) | $ (25,320,555) | $ (25,359,989) | |||||||||
| Annual Meeting of Shareholders [Member] | ||||||||||||
| Common Stock, Shares Authorized | 100,000,000 | 800,000,000 | 800,000,000 | |||||||||
| Common Stock, Par Value | $ 0.00001 | $ 0.00001 | $ 0.00001 | |||||||||
| Description Of Reverse Stock Split | The effective dates of the above actions were June 5, 2020 and April 20, 2020, respectively, and the actual reverse stock split ratio was 1-for-33.26 | reverse stock split of the Company’s outstanding common stock at a ratio between 1-for-32 and 1-for-35 (with the exact ratio to be determined by the directors in their sole discretion without further approval by the shareholders | ||||||||||